United States Ophthalmic Devices Medical Equipment Industry Report

Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Cataract Surgery, Refractive Surgery and Vision Care Equipment, Devices and Supplies

Product Code GMD04496
Publication Date April 2008
Publisher Global Markets Direct
Product Type Report
Pages 278
ISBN Number not applicable
Change currency
PDF £1,895.00 €2,282 $2,996 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

United States Ophthalmic Devices Medical Equipment Industry Report

Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Cataract Surgery, Refractive Surgery and Vision Care Equipment, Devices and Supplies

United States Ophthalmic Devices Medical Equipment Industry Report

Summary

This report is an essential source for in-depth information and data relating to United States ophthalmic devices medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the ophthalmic devices medical equipment in United States.

Scope

  • The report provides sector information broken down into detailed categories and segments in country.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the industry at a global level, with break downs for the country
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 Table Of Contents
    • 1.1 List Of 1.2 List Of 2 Introduction
    • 2.1 What Is This Report About?
    • 2.2 Definitions
      • 2.2.1 Ophthalmic Devices
  • 3 Healthcare Sector Review
    • 3.1 Healthcare Expenditure
    • 3.2 Healthcare Infrastructure
      • 3.2.1 Healthcare Personnel Data
      • 3.2.2 Healthcare Facilities Data
  • 4 Opthalmic Devices in United states
    • 4.1 Ophthalmic Devices Overall Revenues (2000-2012)
    • 4.2 Opthalmic Devices Overall Volume (2000-2012)
    • 4.3 Opthalmic Devices Overall Company Shares (2005-2006)
  • 5 Vision Care in United States
    • 5.1 Vision Care Overall Revenues (2000-2012)
      • 5.1.1 Spectacles Overall Revenues (2000-2012)
      • 5.1.2 Soft Contact Lenses Overall Revenues (2000-2012)
      • 5.1.3 Lens Care Overall Revenues (2000-2012)
      • 5.1.4 Opthalmoscope Overall Revenues (2000-2012)
      • 5.1.5 Rigid Gas Permeable Contact Lenses Overall Revenues (2000-2012)
    • 5.2 Vision Care Overall Volume (2000-2012)
      • 5.2.1 Spectacles Overall Volume (2000-2012)
      • 5.2.2 Soft Contact Lenses Overall Volume (2000-2012)
      • 5.2.3 Lens Care Overall Volume (2000-2012)
      • 5.2.4 Rigid Gas Permeable Contact Lenses Overall Volume (2000-2012)
      • 5.2.5 Opthalmoscope Overall Volume (2000-2012)
    • 5.3 Vision Care Average Price
      • 5.3.1 Lens Care Average Price (2000-2012)
      • 5.3.2 Opthalmoscope Average Price (2000-2012)
      • 5.3.3 Rigid Gas Permeable Contact Lenses Average Price (2000-2012)
      • 5.3.4 Soft Contact Lenses Average Price (2000-2012)
      • 5.3.5 Spectacles Average Price (2000-2012)
    • 5.4 Vision Care Distribution Share (2005-2006)
    • 5.5 Vision Care Company Share (2005-2006)
  • 6 Cataract Surgery in United States
    • 6.1 Cataract Surgery Overall Revenues (2000-2012)
      • 6.1.1 Phacoemulsification Equipment and Accessories Overall Revenues (2000-2012)
      • 6.1.2 Intra Ocular Lens (IOL) Overall Revenues (2000-2012)
    • 6.2 Cataract Surgery Overall Volume (2000-2012)
      • 6.2.1 Intra Ocular Lens (IOL) Overall Volume (2000-2012)
      • 6.2.2 Phacoemulsification Equipment and Accessories Overall Volume (2000-2012)
    • 6.3 Cataract Surgery Average Price (2000-2012)
      • 6.3.1 Intra Ocular Lens (IOL) Average Price (2000-2012)
      • 6.3.2 Phacoemulsification Equipment and Accessories Averaga Price (2000-2012)
    • 6.4 Cataract Surgery Distribution Share (2005-2006)
    • 6.5 Cataract Surgery Company Share (2005-2006)
  • 7 Refractive Surgery in United States
    • 7.1 Refractive Surgery Overall Revenues (2000-2012)
      • 7.1.1 Refractive Surgery Overall Revenues (2000-2012)
    • 7.2 Refractive Surgery Overall Volume (2000-2012)
      • 7.2.1 Refractive Surgery Overall Volume (2000-2012)
    • 7.3 Refractive Surgery Average Price (2000-2012)
      • 7.3.1 Refractive Surgery Average Price (2000-2012)
    • 7.4 Refractive Surgery Distribution Share (2005-2006)
    • 7.5 Refractive Surgery Company Share (2005-2006)
  • 8 Johnson & Johnson Vision Care, Inc. Company Profile
    • 8.1 Company Overview
    • 8.2 Business Overview
      • 8.2.1 Major Products and Services
      • 8.2.2 History
    • 8.3 Locations And Subsidiaries
    • 8.4 Financial Deals Landscape
      • 8.4.1 Essilor International Acquires The Spectacle Lens Group From Johnson & Johnson Vision Care
    • 8.5 Recent Developments
      • 8.5.1 Jan 07, 2008: Court of Appeals Upholds Verdicts in Favor of Cordis Corporation On Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation
  • 9 Advanced Medical Optics, Inc. Company Profile
    • 9.1 Company Overview
    • 9.2 Business Overview
      • 9.2.1 Cataract/Implant
      • 9.2.2 Eye Care
      • 9.2.3 Laser Vision Correction
      • 9.2.4 Major Products and Services
      • 9.2.5 History
    • 9.3
    • 9.4 Value Chain Analysis
      • 9.4.1 Manufacturing
      • 9.4.2 Product Development
      • 9.4.3 Sales and Marketing
    • 9.5 SWOT Analysis
      • 9.5.1 Advanced Medical Optics, Inc. Strengths
      • 9.5.2 Advanced Medical Optics, Inc. Weaknesses
      • 9.5.3 Advanced Medical Optics, Inc. Opportunities
      • 9.5.4 Advanced Medical Optics, Inc. Threats
    • 9.6 Financial and Operational Review
      • 9.6.1 Financial Statements
      • 9.6.2 Financial Ratios
      • 9.6.3 Share Holding Structure
    • 9.7 Locations And Subsidiaries
    • 9.8 Financial Deals Landscape
      • 9.8.1 Advanced Medical Optics Signs An Agreement With Carl Zeiss Meditec
      • 9.8.2 Advanced Medical Optics Acquires Intralase
      • 9.8.3 Advanced Medical Optics Completes Private Placement Of $250 Million
      • 9.8.4 Advanced Medical Optics Acquires Wavefront Sciences
      • 9.8.5 Optobionics Secures $5 Million In Series D-1 Financing
      • 9.8.6 Advanced Medical Optics Completes Private Placement Of $500 Million
      • 9.8.7 Advanced Medical Optics Completes Private Placement Of $150 Million
      • 9.8.8 Advanced Medical Optics Acquires VISX
      • 9.8.9 Advanced Medical Optics Acquires Surgical Ophthalmology Business From Pfizer
      • 9.8.10 Advanced Medical Optics Completes Private Placement Of $350 Million
      • 9.8.11 Advanced Medical Optics Signs An Agreement With Quest Vision Technologies
      • 9.8.12 Advanced Medical Optics to acquire Bausch & Lomb
    • 9.9 Recent Developments
      • 9.9.1 Feb 14, 2008: Advanced Medical Optics Reports Fourth-Quarter and Full-Year 2007 Results
      • 9.9.2 Feb 14, 2008: Advanced Medical Declares Q4 2007 Results
      • 9.9.3 Jan 21, 2008: Advanced Medical Optics Announces Release Date for Fourth Quarter and Full-Year 2007 Operating Results
      • 9.9.4 Dec 05, 2007: AMO Elects Board Members
      • 9.9.5 Nov 19, 2007: AMO Appoints New President
      • 9.9.6 Oct 25, 2007: AMO Declares Q3 2007 Results
      • 9.9.7 Oct 09, 2007: AMO Appoints CFO
      • 9.9.8 Aug 02, 2007: AMO Declares Q2 2007 Results
      • 9.9.9 Jul 23, 2007: AMO Set To Re-Enter Multipurpose Solution Market
      • 9.9.10 Jun 26, 2007: AMO Revises Financial Guidance 2007 And 2008
      • 9.9.11 May 22, 2007: AMO Adds New Board Member
      • 9.9.12 Apr 25, 2007: AMO Declares Q1 2007 Results
      • 9.9.13 Feb 13, 2007: AMO Declares Q4 2006 Results
      • 9.9.14 Oct 26, 2006: AMO Declares Q3 2006 Results
      • 9.9.15 Sep 25, 2006: AMO Lowers 2006 EPS, Revenue Guidance
      • 9.9.16 Aug 01, 2006: AMO Declares Q2 2006 Results
      • 9.9.17 Jun 08, 2006: AMO Increases 2006, 2007 EPS Guidance
      • 9.9.18 May 25, 2006: AMO Appoints Chairman
    • 9.10 Advanced Medical Optics, Inc. Pipeline Products
      • 9.10.1 Sensar Hydrophobic Foldable Intraocular Lenses
      • 9.10.2 Tecnis Multifocal intraocular lens
      • 9.10.3 Presbyopic LASIK multi-focal
      • 9.10.4 Quest accommodating intraocular lens
  • 10 Bausch & Lomb Incorporated Company Profile
    • 10.1 Company Overview
    • 10.2 Business Overview
      • 10.2.1 Cataract and Vitreoretinal Surgery Product Category
      • 10.2.2 Contact Lenses Product Category
      • 10.2.3 Lens Care Product Category
      • 10.2.4 Pharmaceuticals Category
      • 10.2.5 Refractive Surgery Product Category
      • 10.2.6 Major Products and Services
      • 10.2.7 History
    • 10.3 Value Chain Analysis
      • 10.3.1 Manufacturing
      • 10.3.2 Product Development
      • 10.3.3 Sales and Marketing
    • 10.4 SWOT Analysis
      • 10.4.1 Bausch & Lomb Incorporated Strengths
      • 10.4.2 Bausch & Lomb Incorporated Weaknesses
      • 10.4.3 Bausch & Lomb Incorporated Opportunities
      • 10.4.4 Bausch & Lomb Incorporated Threats
    • 10.5 Financial and Operational Review
      • 10.5.1 Financial Statements
      • 10.5.2 Financial Ratios
      • 10.5.3 Share Holding Structure
    • 10.6 Locations And Subsidiaries
    • 10.7 Financial Deals Landscape
      • 10.7.1 Bausch & Lomb Acquires eyeonics
      • 10.7.2 Warburg Pincus Acquires Bausch & Lomb
      • 10.7.3 Bausch & Lomb Completes Private Placement Of $650 Million
      • 10.7.4 Bausch & Lomb Acquires Soothe Emollient (Lubricant) Eye Drops From Alimera Sciences
      • 10.7.5 Bausch & Lomb Acquires Alimera's OTC Eye Care Product
      • 10.7.6 Bausch & Lomb Enters Into A Licensing Agreement With Schering AG
      • 10.7.7 Bayer HealthCare Signs An Agreement With Bausch & Lomb
      • 10.7.8 Bausch & Lomb Signs An Agreement With Cephalon
      • 10.7.9 Bausch & Lomb Signs An Agreement With PTC Therapeutics
      • 10.7.10 Bausch & Lomb Acquires Shandong Chia Tai Freda From Sino Biopharmaceutical
      • 10.7.11 CIBA Vision And Bausch & Lomb Enter Into Cross-License Agreement
      • 10.7.12 Advanced Medical Optics to acquire Bausch & Lomb
      • 10.7.13 Bausch & Lomb Forms A Strategic Alliance With Acufocus
    • 10.8 Recent Developments
      • 10.8.1 Mar 06, 2008: Bausch & Lomb Appoints CVP, CHRO
      • 10.8.2 Feb 05, 2008: J. Raymond Elliott and Richard F. Wallman Join Bausch & Lomb Board of Directors
      • 10.8.3 Feb 05, 2008: Bausch & Lomb Appoints New Directors
      • 10.8.4 Jan 23, 2008: Bausch & Lomb Appoints New CEO
      • 10.8.5 Nov 20, 2007: Bausch & Lomb Appoints Corporate VP And General Counsel
      • 10.8.6 Aug 08, 2007: Bausch & Lomb Reports Q2 2007 Results
      • 10.8.7 Jul 24, 2007: Bausch & Lomb Declares Quarterly Dividend
      • 10.8.8 Jun 26, 2007: Bausch & Lomb Files Suit Against Alcon
      • 10.8.9 May 10, 2007: Bausch & Lomb Preliminary Q1 2007 Results
      • 10.8.10 May 01, 2007: Bausch & Lomb Declares Quarterly Dividend
      • 10.8.11 Mar 19, 2007: Bausch & Lomb Appoints New CFO
      • 10.8.12 Mar 19, 2007: Bausch & Lomb CFO Retires
      • 10.8.13 Mar 06, 2007: Bausch & Lomb Reports Preliminary Q4 And 2006 Results
      • 10.8.14 Feb 26, 2007: Bausch & Lomb Declares Quarterly Dividend
      • 10.8.15 Dec 22, 2006: Bausch & Lomb's Listing On NYSE Extended
      • 10.8.16 Nov 09, 2006: Bausch & Lomb Reports Preliminary Q3 2006 Results
      • 10.8.17 Nov 07, 2006: Bausch & Lomb Declares Quarterly Dividend
      • 10.8.18 Nov 06, 2006: Bausch & Lomb Receives FDA Warning Letter Related To Inspection At Greenville
      • 10.8.19 Jul 25, 2006: Bausch & Lomb Declares Quarterly Dividend
      • 10.8.20 May 02, 2006: Bausch & Lomb Declares Quarterly Dividend
      • 10.8.21 Apr 19, 2006: Bausch & Lomb Names New President For Its Asia Region
    • 10.9 Bausch & Lomb Incorporated Pipeline Products
      • 10.9.1 Safarazi Elliptical Accommodating IOL
      • 10.9.2 Akreos AO Micro-Incision sub-2-mm lens
  • 11 Carl Zeiss Meditec AG Company Profile
    • 11.1 Company Overview
    • 11.2 Business Overview
      • 11.2.1 Diagnosis
      • 11.2.2 Laser and IOL
      • 11.2.3 Service
      • 11.2.4 Major Products and Services
    • 11.3 Value Chain Analysis
      • 11.3.1 Manufacturing
      • 11.3.2 Product Development
      • 11.3.3 Sales and Marketing
    • 11.4 SWOT Analysis
      • 11.4.1 Carl Zeiss Meditec AG Strengths
      • 11.4.2 Carl Zeiss Meditec AG Weaknesses
      • 11.4.3 Carl Zeiss Meditec AG Opportunities
      • 11.4.4 Carl Zeiss Meditec AG Threats
    • 11.5 Financial and Operational Review
      • 11.5.1 Financial Statements
      • 11.5.2 Financial Ratios
    • 11.6 Locations And Subsidiaries
    • 11.7 Financial Deals Landscape
      • 11.7.1 Carl Zeiss Acquires Acri.Tec
      • 11.7.2 Advanced Medical Optics Signs An Agreement With Carl Zeiss Meditec
      • 11.7.3 Carl Zeiss Meditec Acquires 5% Shareholding In Wavelight
      • 11.7.4 Carl Zeiss Meditec Acquires IOLTECH
      • 11.7.5 Carl Zeiss Meditec And PULSION Medical Systems Enter Into Licensing Agreement
    • 11.8 Recent Developments
      • 11.8.1 Mar 27, 2008: Grand Opening: Carl Zeiss opens S$30 million demo facility to boost Singapore's R&D excellence
      • 11.8.2 Jan 22, 2008: New Sales Manager: Reorganization of Sales at Carl Zeiss Sports Optics
      • 11.8.3 Oct 08, 2007: CZM Appoints New Board Member
      • 11.8.4 Aug 23, 2007: CZM Announces Supervisory Board Changes
      • 11.8.5 Aug 08, 2007: CZM First Nine Months 2007 Results
      • 11.8.6 Mar 01, 2007: CZM Reports Fiscal 2005/06 Results
      • 11.8.7 Feb 14, 2007: CZM Reports Q1 2006/07 Results
      • 11.8.8 Nov 13, 2006: CZM Lawsuit with IntraLase
      • 11.8.9 Oct 13, 2006: CZM Wins Against Complainants In Court
      • 11.8.10 Sep 11, 2006: CZM Appoints Executive Board Member
    • 11.9 Carl Zeiss Meditec AG Pipeline Products
      • 11.9.1 IOL Master
      • 11.9.2 VISULAS 690 PLUS
      • 11.9.3 Multifocal IOL
      • 11.9.4 New laser system
      • 11.9.5 VisuCAm platform(New applications)
  • 12 CIBA Vision Corporation Company Profile
    • 12.1 Company Overview
    • 12.2 Business Overview
      • 12.2.1 Major Products and Services
      • 12.2.2 History
    • 12.3 Locations And Subsidiaries
    • 12.4 Financial Deals Landscape
      • 12.4.1 CIBA Vision And CooperVision Enter Into A Licensing Agreement
      • 12.4.2 CIBA Vision And Bausch & Lomb Enter Into Cross-License Agreement
      • 12.4.3 CIBA Vision Sells Its Surgical Business To IOLTECH
      • 12.4.4 CIBA Vision Signs An Agreement With Optonol
    • 12.5 Recent Developments
      • 12.5.1 Nov 21, 2007: CIBA Vision Settles Patent Litigation With CooperVision
      • 12.5.2 Feb 21, 2006: CIBA Vision Appoints New CEO
      • 12.5.3 Apr 02, 2004: CIBA Vision Appoints New Finance Officer
      • 12.5.4 Apr 02, 2004: CIBA Vision Appoints New President
    • 12.6 CIBA Vision Corporation Pipeline Products
      • 12.6.1 Non-Moulded Soft Contact Lenses
  • 13 Regulation System
    • 13.1 Medical Equipment Approval Process
      • 13.1.1 Pre-market Approval Process
      • 13.1.2 Intended use and Indications for use
      • 13.1.3 Predicate Device
      • 13.1.4 Safe and Effective
      • 13.1.5 Other Category Devices
      • 13.1.6 Post-Market Approval Process
      • 13.1.7 Compliance and Enforcement
      • 13.1.8 Registration Fee
      • 13.1.9 Approval Time
  • 14 Pricing and Reimbursement
    • 14.1 Government Policies
    • 14.2 Private Insurance
    • 14.3 Diagnosis Related Groups (DRG)
  • 15 Distribution Structure
    • 15.1 Distribution Structure
  • 16 APPENDIX
    • 16.1 Global Markets Direct Research Methodology
    • 16.2 Coverage
    • 16.3 Secondary Research
    • 16.4 Primary Research
    • 16.5 Models
    • 16.6 Forecasts
    • 16.7 Expert Panels
    • 16.8 Contact Us
    • 16.9 Disclaimer